[ET Net News Agency, 29 May 2020] Sino Biopharmaceutical Limited (01177) said for the
three months ended 31 March 2020, profit attributable to the owners of the parent was
approximately RMB862.02 million, approximately 0.6% higher than that of the same period
last year.
Basic earnings per share attributable to the owners of the parent were approximately
RMB6.85 cent. The board of the company has declared the payment of a quarterly dividend of
HK2 cents per share.
Revenue was approximately RMB6,221.87 million, an increase of approximately 0.2% over
the same period last year. (RC)